The health system has enough beds and ventilators but sometimes not enough staff, echoing concerns from other providers across the nation crushed by the latest wave of coronavirus patients with the fast-spreading omicron variant.
The program will only cover Aduhelm, which the FDA controversially approved last June, for patients enrolled in clinical trials.
“The digital health market wasn’t an across-the-board bubble, but it wasn’t placid water either,” Rock Health researchers said in a new report on investment in the space.
The Biden administration is incentivizing insurers plans to create programs that enable people to get tests from preferred pharmacies without paying upfront or needing to file a reimbursement claim.
Despite consistent revenue growth, the 20-year-old vendor has not yet turned a profit and is currently facing a skeptical market.
The financial pressures, supply chain disruptions and labor challenges brought by the COVID-19 pandemic drove hospitals to seek out merger partners that could help expand their presence in key markets.
Information security analyst took the top spot in the annual list, followed by nurse practitioner, physician assistant, medical and health services manager and software developer.
It’s an unusual step for HHS, given the plan year has already begun, and comes just days before a CMS deadline to issue a draft decision that will shape Aduhelm coverage nationwide.
The insurer has now settled with at least five states, paying out more than $236 million. It’s possible more settlements are on the horizon, as Centene has set aside $1.1 billion for future payments.
The decrease was seen in all U.S. regions except the Northeast, which was particularly slammed with COVID-19 cases and rising hospital admissions during the fall and winter months, Fair Health found.